InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-9.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Sensenig Bethany, Director. Officer active across 2 companies, notably Supernus Pharmaceuticals, INC.. Aggregated, 7 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €399k. History available since 21 April 2023. The latest transaction was disclosed on 19 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
4,475 shares0Common StockSEC:0001899935-26-000005:0
4,475 shares0Common StockSEC:0001899935-26-000005
5,369 shares@ US$42.250.0068% mcap50.0% of flowCommon StockSEC:0001628280-25-040668:0
5,369 shares@ US$42.2550.0% of flowCommon StockSEC:0001628280-25-040668
5,369 shares0Common StockSEC:0001628280-25-007459:0
9,100 shares@ US$1.21100.0% of flowCommon stockSEC:0001551986-23-000026:0
50,177 sharesCommon StockSEC:0001578563-23-000009:0
7 of 7 declarations
About Sensenig Bethany
Bethany Sensenig is a Board Member at Supernus Pharmaceuticals, Inc. She brings expertise in corporate governance and strategy. Her role involves overseeing operations and contributing to strategic decision-making within the company. Through her experience, she plays a key role in shaping governance policies and practices, ensuring compliance and organizational effectiveness.
